NeuroPace, Inc. (NPCE)
8.22
+0.25
(+3.14%)
USD |
NASDAQ |
Nov 17, 16:00
8.35
+0.13
(+1.58%)
After-Hours: 20:00
NeuroPace Enterprise Value : 294.73M for Nov. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 16, 2026 | 294.73M |
| November 13, 2026 | 280.61M |
| November 12, 2026 | 434.18M |
| November 11, 2026 | 451.40M |
| November 10, 2026 | 457.25M |
| November 09, 2026 | 472.06M |
| November 06, 2026 | 450.71M |
| November 05, 2026 | 457.25M |
| November 04, 2026 | 479.63M |
| November 03, 2026 | 444.17M |
| November 02, 2026 | 445.20M |
| October 30, 2026 | 443.82M |
| October 29, 2026 | 468.27M |
| October 28, 2026 | 465.51M |
| October 27, 2026 | 468.61M |
| October 26, 2026 | 467.58M |
| October 23, 2026 | 464.82M |
| October 22, 2026 | 472.74M |
| October 21, 2026 | 469.65M |
| October 20, 2026 | 485.48M |
| October 19, 2026 | 460.00M |
| October 16, 2026 | 441.76M |
| October 15, 2026 | 460.35M |
| October 14, 2026 | 452.77M |
| October 13, 2026 | 456.91M |
| Date | Value |
|---|---|
| October 12, 2026 | 467.92M |
| October 09, 2026 | 456.56M |
| October 08, 2026 | 446.92M |
| October 07, 2026 | 459.66M |
| October 06, 2026 | 456.56M |
| October 05, 2026 | 475.50M |
| October 02, 2026 | 457.59M |
| October 01, 2026 | 473.09M |
| September 30, 2026 | 494.09M |
| September 29, 2026 | 496.13M |
| September 28, 2026 | 503.33M |
| September 25, 2026 | 500.25M |
| September 24, 2026 | 497.16M |
| September 23, 2026 | 505.39M |
| September 22, 2026 | 522.53M |
| September 21, 2026 | 516.70M |
| September 18, 2026 | 507.79M |
| September 17, 2026 | 503.33M |
| September 16, 2026 | 501.62M |
| September 15, 2026 | 506.76M |
| September 14, 2026 | 518.42M |
| September 11, 2026 | 499.56M |
| September 10, 2026 | 493.73M |
| September 09, 2026 | 515.33M |
| September 08, 2026 | 524.24M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tandem Diabetes Care, Inc. | 1.583B |
| Accuray, Inc. | 100.52M |
| Orthofix Medical, Inc. | 452.26M |
| ResMed, Inc. | 33.08B |
| Rockwell Medical, Inc. | 17.84M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.298M |
| Revenue (Quarterly) | 23.10M |
| Total Expenses (Quarterly) | 26.40M |
| EPS Diluted (Quarterly) | -0.096 |
| Gross Profit Margin (Quarterly) | 84.28% |
| Profit Margin (Quarterly) | -14.27% |
| Earnings Yield | -6.79% |
| Normalized Earnings Yield | -6.695 |